Aveanna Healthcare will announce its Q1 results on May 14, 2026, followed by a conference call at 10 a.m. ET.
Quiver AI Summary
Aveanna Healthcare Holdings Inc. announced that it will release its first quarter financial results on May 14, 2026, before the market opens, followed by a conference call at 10:00 a.m. Eastern Time. Participants can join the call by phone or via a live webcast on the company's Investor Relations website. A replay of the call will be available for a week afterward. Aveanna, headquartered in Atlanta, provides a range of healthcare services across 38 states, including nursing, rehabilitation, therapy, and case management services, aiming to offer quality, cost-effective alternatives to hospitalization. Further details can be found on their website.
Potential Positives
- Aveanna Healthcare is set to release its first quarter results, indicating ongoing business operations and financial transparency, which can enhance investor confidence.
- The scheduled conference call and webcast provide an opportunity for stakeholders to engage directly with the company's management, fostering communication and trust.
- The company's diverse range of healthcare services, including pediatric and adult care, highlights its comprehensive approach to meeting patient needs, which can attract more clients and partners.
Potential Negatives
- The timing of the quarterly results release before market open could imply potential unfavorable earnings, contributing to preemptive market speculation or concern among investors.
- The lack of detailed financial forecasts in the announcement may indicate uncertainty about the company's future performance.
- Mention of the company providing a "lower cost alternative to prolonged hospitalization" may raise questions regarding the quality of care or potential cost-cutting measures impacting service standards.
FAQ
When will Aveanna release its first quarter results?
Aveanna will release its first quarter results on Thursday, May 14, 2026, before market open.
What time is the Aveanna conference call scheduled?
The conference call is scheduled for 10:00 a.m. Eastern Time on May 14, 2026.
How can I access the live conference call for Aveanna?
You can dial 1-877-407-0789 for the live call, or 1-201-689-8562 for international callers.
Will there be a replay available for the conference call?
Yes, a replay will be available three hours after the call until May 21, 2026.
Where can I find more information about Aveanna Healthcare?
For more information, visit Aveanna's official website at www.aveanna.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$AVAH Insider Trading Activity
$AVAH insiders have traded $AVAH stock on the open market 37 times in the past 6 months. Of those trades, 0 have been purchases and 37 have been sales.
Here’s a breakdown of recent trading of $AVAH stock by insiders over the last 6 months:
- PAUL R VIGANO has made 0 purchases and 3 sales selling 1,500,000 shares for an estimated $13,500,000.
- ROBERT M JR WILLIAMS has made 0 purchases and 3 sales selling 1,500,000 shares for an estimated $13,500,000.
- WHITNEY EQUITY PARTNERS VII, LLC J.H. sold 1,251,909 shares for an estimated $11,267,181
- JEFF SHANER (Chief Executive Officer) has made 0 purchases and 6 sales selling 546,869 shares for an estimated $4,101,383.
- EDWIN C. REISZ (Chief Administrative Officer) has made 0 purchases and 6 sales selling 213,013 shares for an estimated $1,610,700.
- MATTHEW BUCKHALTER (Chief Financial Officer) has made 0 purchases and 6 sales selling 89,107 shares for an estimated $697,150.
- PATRICK A. CUNNINGHAM (Chief Compliance Officer) has made 0 purchases and 6 sales selling 85,175 shares for an estimated $655,556.
- DEBORAH STEWART (SVP, Chief Accounting Officer) has made 0 purchases and 6 sales selling 64,431 shares for an estimated $501,322.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AVAH Revenue
$AVAH had revenues of $662.5M in Q4 2025. This is an increase of 27.43% from the same period in the prior year.
You can track AVAH financials on Quiver Quantitative's AVAH stock page.
$AVAH Hedge Fund Activity
We have seen 123 institutional investors add shares of $AVAH stock to their portfolio, and 63 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J.H. WHITNEY EQUITY PARTNERS VII, LLC removed 9,597,968 shares (-20.9%) from their portfolio in Q4 2025, for an estimated $78,415,398
- LITTLEJOHN & CO LLC removed 3,140,105 shares (-52.9%) from their portfolio in Q4 2025, for an estimated $25,654,657
- SUMMIT PARTNERS L P removed 2,100,000 shares (-21.8%) from their portfolio in Q4 2025, for an estimated $17,157,000
- AUSTRALIANSUPER PTY LTD removed 1,774,837 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $14,500,418
- EMERALD ADVISERS, LLC added 1,748,725 shares (+inf%) to their portfolio in Q4 2025, for an estimated $14,287,083
- VANGUARD GROUP INC added 1,535,351 shares (+38.0%) to their portfolio in Q4 2025, for an estimated $12,543,817
- CITADEL ADVISORS LLC added 1,511,417 shares (+3938.3%) to their portfolio in Q4 2025, for an estimated $12,348,276
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AVAH Analyst Ratings
Wall Street analysts have issued reports on $AVAH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 12/08/2025
- BMO Capital issued a "Outperform" rating on 11/13/2025
To track analyst ratings and price targets for $AVAH, check out Quiver Quantitative's $AVAH forecast page.
$AVAH Price Targets
Multiple analysts have issued price targets for $AVAH recently. We have seen 6 analysts offer price targets for $AVAH in the last 6 months, with a median target of $9.75.
Here are some recent targets:
- David Macdonald from Truist Securities set a target price of $8.0 on 04/13/2026
- Andrew Mok from Barclays set a target price of $9.5 on 03/25/2026
- Ben Hendrix from RBC Capital set a target price of $9.0 on 03/23/2026
- Sean Dodge from BMO Capital set a target price of $10.0 on 03/20/2026
- A.J. Rice from UBS set a target price of $10.0 on 01/15/2026
- Brian Tanquilut from Jefferies set a target price of $12.5 on 10/28/2025
Full Release
ATLANTA, April 23, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 14, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13759633. The replay will be available until May 21, 2026.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://ir.aveanna.com/ . The online replay will be available for one week following the call.
About Aveanna Healthcare
Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com .
